A Study to Test How Different Doses of BI 1815368 Are Tolerated and How BI 1815368 is Taken up in the Body of Healthy Japanese Men
Clinical trial NCT06494774 · COMPLETED
Trial details
- NCT number
- NCT06494774
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-19
- Primary completion
- 2024-11-13
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.